Following SpaceX's initial public offering on June 12, 2026, multiple members of Congress, including Rep. William Timmons, purchased shares of the company, with total reported investments ranging from approximately $83,000 to $245,000.
This activity has drawn scrutiny due to the lawmakers' committee assignments that oversee sectors critical to SpaceX's operations, such as defense and artificial intelligence.
While there is no evidence of insider trading or violations of congressional trading rules, ethics experts warn that these transactions could create the appearance of conflicts of interest, especially since the company is heavily dependent on federal contracts.
The stock's performance has been volatile, initially priced at $135, peaking at $201.80, and closing at $113.46, about 16% below its IPO price.
The situation highlights ongoing debates about the appropriateness of congressional stock trading, particularly in companies that are significant government contractors, and raises questions about the ethical implications of lawmakers profiting from investments in firms they oversee